New study tracks odevixibat safety in pregnancy and breastfeeding
NCT ID NCT06258902
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study follows people of any age who have taken the drug odevixibat while pregnant or breastfeeding. Researchers will collect routine medical data to check for any effects on the mother, developing baby, or infant. No extra tests or visits are required beyond normal care. The goal is to better understand the risks, if any, of using this drug during pregnancy and lactation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY RELATED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Virtual Research Coordination Center Odevixibat (BYLVAY) Pregnancy Surveillance Program
RECRUITINGWilmington, North Carolina, 28401, United States
Conditions
Explore the condition pages connected to this study.